Novartis, Genentech Again Beat Xolair Kickback Suit
By Dani Kass · October 5, 2017, 4:24 PM EDT
Whistleblowers accusing Novartis Pharmaceuticals Corp. and Genentech Inc. of paying physicians kickbacks to boost prescriptions for the asthma medication Xolair had their suit dismissed a second time Tuesday, with a New...
To view the full article, register now.